Skip to results
Modify your search
NARROW
1-3 of 3
Authors: Pål A Holme
Sort by
Journal Article
Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy: A clinical consensus statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care (ACVC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Heart Rhythm Association (EHRA) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy and the European Association for Haemophilia and Allied Disorders (EAHAD)
Dan Atar and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 3, May 2025, Pages 275–289, https://doi.org/10.1093/ehjcvp/pvaf006
Published: 26 March 2025
Journal Article
Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia
Sverre Holm and others
European Heart Journal, Volume 42, Issue 39, 14 October 2021, Pages 4064–4072, https://doi.org/10.1093/eurheartj/ehab506
Published: 18 August 2021
Journal Article
Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
Andreas Barratt-Due and others
in
Rheumatology
Rheumatology, Volume 55, Issue 7, July 2016, Pages 1337–1339, https://doi.org/10.1093/rheumatology/kew040
Published: 22 April 2016
Advertisement
Advertisement